
Sébastien Repplinger, with Gwenaëlle Jacq, Stéphane Legriel and the teams of 26 ICUs in the network, has published in Neurology a study from the ICTAL Registry on etiologic investigations in status epilepticus.
The question : status epilepticus requires prompt symptomatic and etiologic treatment, but the diagnostic yield of etiologic investigations remains poorly characterized. The study evaluated the diagnostic yield and therapeutic impact of each test according to the pretest probability of each cause.
Methods : a prospective multicenter cohort in 26 university-affiliated French ICUs (2018–2025), including all adults admitted for status epilepticus. Patients underwent a predefined diagnostic protocol: brain imaging (CT or MRI), laboratory tests, lumbar puncture, toxicology screening, antiseizure medication assays and paraneoplastic or autoimmune workup. The primary outcome was the diagnostic yield of each test (confirmation, codiagnosis or reclassification of etiology); the secondary outcome was management changes directly attributable to test results.
Results : among 1,123 patients (64% male, median age 60 years), status epilepticus was motor-predominant in 90%. In high pretest probability strata, first-line investigations confirmed the suspected etiology in 8.5–44.5% of cases and reclassified it in 22.1–35.1%. Confirmation rates were highest for toxicology screening in toxic or iatrogenic causes (44.5%), antiseizure medication assays in precipitating factors (44.0%), autoimmune workup in noninfectious encephalitis (40.0%) and brain CT in vascular causes (28.0%). Reclassification was mainly driven by brain MRI (27.8–35.1%). Management changes were most frequent after brain MRI (up to 58.3%) and brain CT (up to 56.9%), followed by lumbar puncture (39.4%), antiseizure medication assays (up to 35.1%) and autoimmune workup (33.3%).
In practice : the yield and impact of investigations depend strongly on clinical pretest probability. Stratified diagnostic strategies may optimize etiologic identification and guide timely, targeted interventions.
Reference: Repplinger S, Chelly J, Lesieur O, et al. Diagnostic yield and therapeutic impact of etiologic investigations after status epilepticus: insights from the ICTAL Registry. Neurology 2026;107:e218544. doi.org/10.1212/WNL.0000000000218544








You must be logged in to post a comment.